North American Tuberculosis Diagnosis and Treatment Market Industry Key Players, Trends, Sales, Supply, Demand, Analysis & Forecast to 2025

North American tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around -0.3% during the forecast period. High prevalence of tuberculosis along with the favorable health coverage policies in the region is one of the major factors for the growth of the market. According to World Economic Forum North America has one of the strong economies that comprises of 27.95 % of World economy that is one of the factors that affects the healthcare market. Among the two countries the US have higher healthcare expenditure as compared to Canada. Additionally, stronger growth in spending for private hospital care, physician, health insurance and clinical services has been driving the market growth. Moreover, the healthcare spending and public spending reflects the demand of tuberculosis diagnosis tools and therapeutics and acts as a major motivator of this market.

Get Sample Copy of North American Tuberculosis Diagnosis and Treatment Market at: https://www.omrglobal.com/request-sample/north-american-tuberculosis-diagnosis-treatment-market

The key players that are active in the market include Abbott Laboratories, Akonni Biosystems, Inc., Alere Inc., Becton, Dickinson and Co., Cepheid, Inc., Hologic, Inc., Johnson & Johnson, Novartis AG, Pfizer Inc. and Thermo Fisher Scientific.

North American tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing.

For More Information, get A full report of North American Tuberculosis Diagnosis and Treatment Market is available at: https://www.omrglobal.com/industry-reports/north-american-tuberculosis-diagnosis-treatment-market

For instance, recently, in November, 2017, Akonni Biosystems accounted for a receipt of $300K Commercial Readiness Pilot (CRP) grant from the National Institutes of Health (NIH). This grant enabled Akonni for a faster commercialization of its TruArray MDR-TB test on its TruDx 3000 sample-to-answer diagnostic platform. Additionally, the major activity was recorded in October, 2017 when Alere Inc., Massachusetts based rapid point-of-care diagnostics provider got acquired by Abbott Laboratories. Alere's complementary technologies will assist the acquiring company in providing better care for patients.

Market Segmentation

Tuberculosis Diagnosis and Treatment Market by Drugs Type

o First Line Drugs
o Second Line Drugs

Tuberculosis Diagnosis and Treatment Market by Diagnosis

o Laboratory Testing
o Nucleic Acid Amplification Test
o Mantoux Test
o Radiography
o Drug Susceptibility Testing

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/north-american-tuberculosis-diagnosis-treatment-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.